Interestingly, in our cohort of patients, Myostatin concentrations were not further decreased in patients that fulfilled sepsis criteria (compared to patients with systemic inflammatory distress syndrome, SIRS) highlighting that rather the presence of systemic inflammation than bacterial infection is the main driver of decreased Myostatin serum concentrations in critically ill patients. The gene discussed is MSTN; the disease is bacterial infectious disease.